Dr. Reddy’s Laboratories SA, Switzerland, (DRSA) a wholly- owned subsidiary of the company, has incorporated a new wholly-owned subsidiary in Denmark, named “Dr. Reddy's Denmark ApS” on October 4, 2024. Accordingly, Dr. Reddy's Denmark ApS is a step-down wholly-owned subsidiary of the company.

The authorized share capital is DKK 40.000 divided into shares of DKK 1 or multiples thereof. The company will focus on production of any pharmaceutical and biotechnological products, the acquisition, use, purchase and sale of goods of all kinds and in particular of intellectual property rights and activities related hereto. The business of the Dr. Reddy's Denmark ApS is in line with the main line of business of the company.